Archford Capital Strategies, LLC

Position in EXEL — Exelixis, Inc.

CIK 1606609 SWANSEA, IL

Position in EXEL

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$709,397

-$525,142 QoQ

Shares Held

13,038

-56.4% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#381

of 751 holders

Holding Since

Sep 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Archford Capital Strategies, LLC holds $1,967,528 across 3 Biotechnology names. EXEL ranks #1 (36.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc. This page	13,038	$709,397
2	REGN	Regeneron Pharmaceuticals, Inc.	1,043	$650,352
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,019	$607,779

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$709,397	13,038	-56.4%	Shares	Sole	2026-07-17
2025-09-30	$1,234,539	29,892	—	Shares	Sole	2025-10-17
No filing history on record for this holder in this stock.